APA (7th ed.) Citation

P, Z., H, G., S, Y., H, C., J, Z., Z, Z., . . . L, Z. (2022). Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors. Nature communications, 13(1), 7025. https://doi.org/10.1038/s41467-022-34545-6

Chicago Style (17th ed.) Citation

P, Zhang, et al. "Author Correction: Targeting Myeloid Derived Suppressor Cells Reverts Immune Suppression and Sensitizes BRAF-mutant Papillary Thyroid Cancer to MAPK Inhibitors." Nature Communications 13, no. 1 (2022): 7025. https://doi.org/10.1038/s41467-022-34545-6.

MLA (9th ed.) Citation

P, Zhang, et al. "Author Correction: Targeting Myeloid Derived Suppressor Cells Reverts Immune Suppression and Sensitizes BRAF-mutant Papillary Thyroid Cancer to MAPK Inhibitors." Nature Communications, vol. 13, no. 1, 2022, p. 7025, https://doi.org/10.1038/s41467-022-34545-6.